OverviewChartNewsTraderScreen

BVT Call 200 PGR 20.09.2024/  DE000VM84XH7  /

Frankfurt Zert./VONT
2024-05-07  10:24:24 AM Chg.+0.140 Bid10:59:10 AM Ask10:59:10 AM Underlying Strike price Expiration date Option type
2.500EUR +5.93% 2.430
Bid Size: 5,000		 2.480
Ask Size: 5,000		 Progressive Corporat... 200.00 USD 2024-09-20 Call
GlobeNewswire 9:00 AM EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial...
GlobeNewswire 05-06 Day One Reports First Quarter 2024 Financial Results and Corporate Progress
GlobeNewswire 05-06 NewtekOne, Inc. Reports First Quarter 2024 Financial Results
GlobeNewswire 05-06 ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
GlobeNewswire 05-06 TYLin Strengthens Southern California Water Sector Leadership
GlobeNewswire 05-06 IRSA: Promote the continuous development of China-France comprehensive strategic partnership
GlobeNewswire 05-06 4 Gen Logistics Advances Sustainable Goods Movement with 41 Volvo VNR Electric Trucks
GlobeNewswire 05-06 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire 05-04 The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats
GlobeNewswire 05-02 PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...
GlobeNewswire 05-01 Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire 05-01 Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...
GlobeNewswire 05-01 Opthea Announces Upcoming Presentations at the Retina World Congress 2024
GlobeNewswire 05-01 Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...
GlobeNewswire 05-01 TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 04-30 Progressive Announces Investor Relations Call
GlobeNewswire 04-25 Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...
GlobeNewswire 04-25 Opthea to Present at the OIS Retina Innovation Summit at ARVO
TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 04-24 Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...
TeleTrader 04-23 Biden meets AOC amid divide on Israel policy
GlobeNewswire 04-22 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire 04-22 Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients i...
GlobeNewswire 04-19 Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Scleros...
GlobeNewswire 04-18 Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with B...